Search results
1 mar 2023 · Up to 10% of children with S. aureus AHO will experience acute complications (e.g., treatment failure within 6 weeks of antibiotic therapy initiation, prolonged hospitalization) as well as long-term morbidity (e.g., growth arrest of the affected limb or limb length discrepancy, pathologic fractures, avascular necrosis, chronic dislocation ...
- Community-acquired methicillin-resistant Staphylococcus aureus causes ...
Community-acquired methicillin-resistant Staphylococcus...
- Community-acquired methicillin-resistant Staphylococcus aureus causes ...
Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infection in children is increasingly common and can be associated with dissemination and life-threatening complications. Empiric therapy for presumed severe Staphylococcus aureus infection should be reviewed.
Introduction. Antibiotic resistance is a big problem during the treatment of bacterial infections. While antibiotics are an effective means to control such infections, antibiotic overuse triggers the spread of resistant strains in the population.
10 paź 2021 · USA300 CA-MRSA strains are no longer the predominant cause of invasive infections in children in the U.S. Rather, a more diverse group of currently circulating S. aureus strains populate the landscape, and the majority of infections now appear to be MSSA, with rates of paediatric bloodstream infection due to MSSA progressively rising since ...
27 gru 2015 · CA-MRSA commonly causes skin and soft tissue infections in previously healthy children. CA-MRSA infection is well known in many countries and has become common in the United States, Taiwan, Canada, European countries, and Australia. ... The disease, which leads to complications such as meningitis, osteomyelitis, fasciitis, necrotizing pneumonia ...
12 sty 2023 · The prevention and control of methicillin-resistant Staphylococcus aureus (MRSA) infections in children will be discussed here. The epidemiology, clinical spectrum, and treatment of MRSA in children are discussed separately.
1 lut 2011 · For health care–associated MRSA (HA-MRSA) or CA-MRSA pneumonia, IV vancomycin (A-II) or linezolid 600 mg PO/IV twice daily (A-II) or clindamycin 600 mg PO/IV 3 times daily (B-III), if the strain is susceptible, is recommended for 7–21 days, depending on the extent of infection.
